Discontinuation of antiseizure medication (ASM) at discharge after acute symptomatic neonatal seizures appears to be safe. A comparative effectiveness study of 303 children found most (64%) were maintained on ASM, usually phenobarbital (90%), beyond resolution and discharge. The US study found the rate of impaired functional neurodevelopment at 24 months was similar in those discontinued ...
New evidence supports discontinuation of antiseizure medications in neonates
By Mardi Chapman
1 Jun 2021